Literature DB >> 237498

A primate model for testing anticonvulsant drugs.

B S Meldrum, R W Horton, P A Toseland.   

Abstract

Senegalese baboons (Papio papio), with a natural syndrome of photosensitive epilepsy, consistently show generalized myoclonic jerks if stimulated stroboscopically at hourly intervals, two to eight hours after the intravenous administration of allylglycine, 200 mg/kg. This provides a model for testing the acute antiepileptic effects of established or new drugs. The relationship between concentration of drug, antiepileptic action, and acute neurological toxic effects can be studied. Pnehobarbital (15 mg/kg) and diazepam (0;5 to 1.5 mg/kg) were highly effective in the absence of signs of toxic reaction (plasma levels: phenobarbital sodium, 0.7 to 1.7 mg/100 ml; diazepam, greater than 0.5 mug/ml). After administration of carbamazepine (30 to 40 mg/kg) and diphenylhydantoin sodium (40 to 50 mg/kg), antiepileptic action was seen, but was accompanied by severe toxic signs (nystagmus and ataxia). Sulthiame (20 to 125 mg/kg) and ethosuximide (50 to 100 mg/kg) had little antiepileptic activity and no acute toxic effects. This primate model may aid the identification of new drugs that are active against grand mal seizures and status epilepticus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 237498     DOI: 10.1001/archneur.1975.00490470033003

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

1.  Anticonvulsant action of YG 19-256 in baboons with photosensitive epilepsy.

Authors:  B S Meldrum; R W Horton
Journal:  Experientia       Date:  1979-06-15

2.  Catalytic inhibitors of GABA-transaminase as anticonvulsants in baboons with photosensitive epilepsy [proceedings].

Authors:  R W Horton; B S Meldrum
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

3.  Clobazam: anticonvulsant action in animal models of epilepsy [proceedings].

Authors:  B S Meldrum; A G Chapman; R W Horton
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

4.  ZK 91296, a partial agonist at benzodiazepine receptors.

Authors:  E N Petersen; L H Jensen; T Honoré; C Braestrup; W Kehr; D N Stephens; H Wachtel; D Seidelman; R Schmiechen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.

Authors:  G Anlezark; B Meldrum
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

6.  Blockade of epileptic responses in the photosensitive baboon, Papio papio, by two irreversible inhibitors of GABA-transaminase, gamma-acetylenic GABA (4-amino-hex-5-ynoic acid) and gamma-vinyl GABA (4-amino-hex-5-enoic acid).

Authors:  B Meldrum; R Horton
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

7.  Changes in noradrenergic neuroendocrine responses following repeated seizures and the mechanism of action of ECT.

Authors:  J R McWilliam; B S Meldrum; S A Checkley
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  The relationship between the anticonvulsant properties of SC-13504 and its plasma levels, measured by polarography, in baboons with photosensitive epilepsy.

Authors:  B S Meldrum; M R Smyth; W Franklin-Smyth; J M Clifford
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

Review 9.  GABAergic mechanisms in the pathogenesis and treatment of epilepsy.

Authors:  B S Meldrum
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 10.  Strategies for identifying and developing new anticonvulsant drugs.

Authors:  H J Kupferberg
Journal:  Pharm Weekbl Sci       Date:  1992-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.